Colony-stimulating factor-1 mediates macrophage-related neural damage in a model for Charcot–Marie–Tooth disease type 1X

Functional role of brain-derived neurotrophic factor in neuroprotective autoimmunity: therapeutic implications in a model of multiple sclerosis

(2011) R. A. Linker et al.   BRAIN

Inherited Neuropathies

(2011) Angelo Schenone et al.   Current Treatment Options in Neurology

Macrophages Counteract Demyelination in a Mouse Model of Globoid Cell Leukodystrophy

(2011) Y. Kondo et al.   JOURNAL OF NEUROSCIENCE

Charcot-Marie-Tooth disease

(2011) Mary M. Reilly et al.   JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM

Ascorbic acid in Charcot–Marie–Tooth disease type 1A (CMT-TRIAAL and CMT-TRAUK): a double-blind randomised trial

(2011) Davide Pareyson et al.   LANCET NEUROLOGY

MCP-1/CCL2 Modifies Axon Properties in a PMP22-Overexpressing Mouse Model for Charcot-Marie-Tooth 1A Neuropathy

(2010) Bianca Kohl et al.   AMERICAN JOURNAL OF PATHOLOGY

Fibrocytes in health and disease

(2010) Erica L. Herzog et al.   EXPERIMENTAL HEMATOLOGY

Attenuation of MCP-1/CCL2 expression ameliorates neuropathy in a mouse model for Charcot–Marie–Tooth 1X

(2010) Janos Groh et al.   HUMAN MOLECULAR GENETICS

Functional overlap but differential expression of CSF-1 and IL-34 in their CSF-1 receptor-mediated regulation of myeloid cells

(2010) Suwen Wei et al.   JOURNAL OF LEUKOCYTE BIOLOGY

Myelination and support of axonal integrity by glia

(2010) Klaus-Armin Nave   NATURE

Activation and deactivation of periventricular white matter phagocytes during postnatal mouse development

(2009) Mariya Hristova et al.   GLIA

Myelin under stress

(2009) Maurizio D'Antonio et al.   JOURNAL OF NEUROSCIENCE RESEARCH

Charcot–Marie–Tooth disease type 1A: is ascorbic acid effective?

(2009) Davide Pareyson et al.   LANCET NEUROLOGY

Ascorbic acid for Charcot–Marie–Tooth disease type 1A in children: a randomised, double-blind, placebo-controlled, safety and efficacy trial

(2009) Joshua Burns et al.   LANCET NEUROLOGY

Effect of ascorbic acid in patients with Charcot–Marie–Tooth disease type 1A: a multicentre, randomised, double-blind, placebo-controlled trial

(2009) Joëlle Micallef et al.   LANCET NEUROLOGY

Molecular mechanisms of inherited demyelinating neuropathies

(2008) Steven S. Scherer et al.   GLIA

Interactions between Schwann cells and macrophages in injury and inherited demyelinating disease

(2008) Rudolf Martini et al.   GLIA

Increase of MCP-1 (CCL2) in myelin mutant Schwann cells is mediated by MEK-ERK signaling pathway

(2008) Stefan Fischer et al.   GLIA

Identity, developmental restriction and reactivity of extralaminar cells capping mammalian neuromuscular junctions

(2008) F. A. Court et al.   JOURNAL OF CELL SCIENCE

The selective M-CSF receptor tyrosine kinase inhibitor Ki20227 suppresses experimental autoimmune encephalomyelitis

(2008) Yasunori Uemura et al.   JOURNAL OF NEUROIMMUNOLOGY

Ablation of the UPR-Mediator CHOP Restores Motor Function and Reduces Demyelination in Charcot-Marie-Tooth 1B Mice

(2008) Maria Pennuto et al.   NEURON

The orally-active and selective c-Fms tyrosine kinase inhibitor Ki20227 inhibits disease progression in a collagen-induced arthritis mouse model

(2007) Hiroaki Ohno et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Monocyte chemoattractant protein-1 is a pathogenic component in a model for a hereditary peripheral neuropathy

(2007) Stefan Fischer et al.   MOLECULAR AND CELLULAR NEUROSCIENCE